ABSTRACT
Background: Alterations in the metabolism of some essential micronutrients and activities of some metabolic enzymes have been reported in diabetes mellitus. These changes have been attributed to hyperglycemia and increased protein glycosylation associated with diabetes and seems to be more pronounced in poor glycemic states. The influence of glycemic control on serum levels of calcium (Ca), Iron (Fe), phosphorus (P), vitamin C, and lactate dehydrogenase (LDH) and amylase activity in type 2 diabetes were determined in this study. Methods: Fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), serum calcium (Ca), Iron (Fe), phosphorus (P), vitamin C, LDH and amylase activity were determined in fifty type 2 diabetic subjects aged between 40-70 years and fifty age matched apparently healthy non-diabetic subjects in Calabar, Nigeria using colorimetric methods. Socio-demographic characteristics, anthropometric indices (body mass indices (BMI), waist to hip ratio (WHR)) and blood pressure were determined using standard methods. Data was analyzed using t-test, ANOVA and Pearson correlation analysis at p = 0.05. Results: The FPG, HbA1c, serum vitamin C, Iron and calcium levels were significantly higher and serum phosphorus lower in diabetics than in non-diabetics. Diabetics with poor glycemic control (HbA1c >8.0%) have higher serum calcium and LDH activity compared to those with good glycemic control (HbA1c <8.0%). Conclusions: Diabetes may alter the metabolism of vitamin C, Iron, calcium and phosphorus while poor glycemic control may be associated with changes in calcium and LDH activity.
ABSTRACT
Background: Adiponectin has been associated with insulin resistance and dyslipidemia in Type 2 diabetes, though the mechanism of association is still uncertain. The adiponectin levels and lipid profile in relation to glycemic control were investigated in type 2 diabetics. Methods: Forty two diabetic subjects (35-64 years) and 33 age-matched non-diabetic subjects were recruited into this case control study. Socio-demographic characteristics, anthropometric indices and blood pressure were obtained. Total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL), high density lipoprotein, (HDL), fasting plasma glucose (FPG), and glycated hemoglobin (HbA1c) were estimated using colorimetric methods, atherogenic index (AI) was calculated, while serum adiponectin was determined by ELISA method. Results: Adiponectin levels of type 2 diabetics were not significantly different from the non-diabetics studied (p>0.05). Higher TG levels were observed in diabetics with poor glycemic control compared with those with good glycemic control (p<0.05). Hypertensive diabetics have higher TC and lower HDL-C levels compared with non hypertensive diabetics (p<0.05). Adiponectin correlated positively with HDL-C (r = 0.739, p = 0.01) and negatively with AI (r = -0.539, p = 0.001) only in the non diabetic group. No significant differences were observed in the adiponectin levels in relation with gender, duration of diabetes and glycemic state (p>0.05). Conclusion: Type 2 diabetics do not have lower adiponectin levels. Gender, duration of diabetes and glycemic control does not seem to exert any influence on adiponectin levels in type 2 diabetes. Adiponectin may be associated with reduced risk of atherosclerosis through its effects on HDL cholesterol metabolism.